Q4 2025 earnings call: 15% revenue growth, $3.9M sales, CapsoCam Colon Gen 2/AI 510(k) timing, trials & funding—read now.
20.48 In 2025, the company's net pro?t attributable to the parent company increased by 20.48% 2 R&D investment grew by 9.96% Overseas sales revenue rose by 45.52%. 9.96 45.52 HGTECH deeply implements ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果